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Abstract
The connection between the heart and the brain has long been anecdotally recognized but
systematically studied only relatively recently. Cardiac arrhythmias, especially sudden cardiac
death, remain a major public health concern and there is mounting evidence that psychological
distress plays a critical role as both a predictor of high-risk cardiac substrate and as an inciting
trigger. The transient, unpredictable nature of emotions and cardiac arrhythmias have made their
study challenging, but evolving technologies in monitoring and imaging along with larger
epidemiological data sets have encouraged more sophisticated studies examining this relationship.
Here we review the research on psychological distress including anger, depression and anxiety on
cardiac arrhythmias, insights into proposed mechanisms, and potential avenues for future research.
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“Alas, my liege, my wife is dead tonight; Grief of my son’s exile hath stopp’d her
breath”
-Romeo and Juliet Act 5 Scene 3 Line 218–219
Montague over his wife’s sudden death.
A systematic review of Shakespeare’s works cites ten deaths due to strong emotions with
three of them occurring on stage,1 so the impact of psychological distress on mortality has
long been intuited. Similarly, sudden cardiac death (SCD) and ventricular arrhythmias have
been observed in response to disasters associated with intense emotion2–5. Recognition of
the importance of psychological factors in the development of cardiac arrhythmias in
cardiovascular research has grown with increased understanding about the brain-heart
connection. In this review we seek to address some of the challenges in investigating
emotional factors in arrhythmia, discuss the recent work in this field, and outline potential
avenues for future research.
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Initiation of an arrhythmic event often requires both a susceptible myocardial substrate and
an inciting trigger. For instance, in the case of ischemic ventricular tachycardia (VT), the
scar from prior myocardial infarction (MI) demonstrates intermingling of fibrous tissue and
surviving myocardial fibers that results in delayed impulse conduction6, as well as reduced
cell-to-cell coupling particularly in the infarct border zone7. This substrate may remain
clinically silent until an inciting trigger such as a ventricular premature complex initiates
sustained re-entry, thereby exposing the vulnerable substrate.
Emotional factors may exhibit both substrate and triggering relationships with arrhythmia
(Figure 1), and one useful categorization differentiates stable traits from more transient
states. Someone may have a tendency toward anger, but nonetheless may not actually
experience the state of anger in a given period as much as another person who repeatedly
faces anger-inducing stressors. Psychological traits and states have different conceptual
constructs and measurement instruments. For instance, Type D personality is a stable
personality type that manifests as a tendency toward negative emotions and against sharing
these emotions with others due to fear of rejection8. Stable traits may reinforce the triggering
phenomenon associated with a transient emotional state9.
The fact that emotional states and arrhythmia can each occur unexpectedly and transiently
poses difficulties in assessing the relationships between the two. In the cardiac literature,
measurement of symptoms of psychological distress has often relied on self-report
questionnaires or on structured interviews performed at one point in time. Clearly this is not
as comprehensive as a repeated assessment, and the unreliability of a single assessment may
account for some of the variability in estimated associations. More recently, electronic
diaries have been used to perform ecological momentary assessment, where real-time
symptoms are prospectively captured over the course of the day10. Arrhythmia measurement
has also improved in the past decade through the adoption of technologies such as
intracardiac recordings from implanted devices, and through mobile cardiac telemetry
monitoring in patients without such devices. However, even with continuous measurement,
arrhythmia over the course of one week or even one month is likely to be rare, unless a high
risk sample is studied. Implantable cardioverter-defibrillator (ICD) patients have frequently
been studied for emotional correlates with arrhythmia, but studies in the general population
require many more observations over long periods of time.
Even with emerging evidence demonstrating associations between psychosocial factors and
cardiac arrhythmias, the causal direction is difficult to assess (Figure 1). Individuals who
have frequent arrhythmias are potentially more likely to develop depressive symptoms and
anxiety due to the somatic symptoms associated with the arrhythmia, or from the treatments
– such as defibrillator therapy - necessitated by their arrhythmia. An association between the
putative psychosocial risk factor and the arrhythmic outcome may partly reflect this ‘reverse
causality.’
Medications that are used to treat individuals with psychiatric disorders may themselves
affect the risk of cardiac arrhythmia. For instance, antipsychotic medications11 and certain
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antidepressant medications12 carry a known risk of affecting repolarization and causing
torsades de pointes. Separating the effects of psychiatric disorders versus treatment is often
impossible in observational studies13.
Human studies of emotion and arrhythmia
There is a wealth of epidemiologic evidence involving psychosocial factors and ventricular
arrhythmia; for an excellent summary of the literature through 1999 please see the review by
Hemingway and colleagues14. Here we review the more recent observational and clinical
research data, from a symptom-specific perspective, and also discuss data involving atrial
fibrillation (AF).
Anger
Among emotional factors, anger has been relatively well-characterized particularly within
the conceptual framework of its triggering effect on ventricular arrhythmia. Lampert et al.15
used a case-crossover study design to evaluate emotional triggers of shock for ventricular
arrhythmia among 277 ICD patients. Patients were instructed to record their mood states in
structured diaries both at the time of an ICD shock and during a later control period. Anger
was more frequent in the 15 minutes preceding shock, compared with control periods (odds
ratio 1.8, 95% CI 1.04–3.16; p<0.04), although other mood states such as anxiety, worry,
sadness, and happiness did not differ. Burg et al.9 studied the same sample of patients
further, and found in multivariable analyses that the 17 patients who reported at least
moderate anger in the 15 minutes before shock had significantly higher scores on the
Speilberger Trait Anger measure, suggesting that stable traits may identify patients at risk
for emotion-triggered arrhythmias. VT episodes triggered by anger in ICD patients were
more likely to be pause-dependent and polymorphic16.
Depression
As opposed to anger, depression and depressed mood have been studied more for their
longer term relationships with arrhythmia risk. This focus may reflect the well-known
impact of depression on long-term prognosis in patients with coronary artery disease17,18.
Also, depression has been studied more frequently for its association with endpoints such as
sudden cardiac death (SCD). Although SCD is often due to VT or ventricular fibrillation
(VF), the proportion of SCD that is due to pulseless electrical activity, which typically does
not have an arrhythmic component, has been increasing especially among patients without
coronary artery disease19.
In a case-control study, Empana et al.20 examined data from enrollees of a health
maintenance organization in Washington State. Cases of out-of-hospital cardiac arrest
(n=2228) among patients aged 40–79 years were identified from emergency medical service
incident reports, and ambulatory medical records were examined for diagnoses of clinical
depression. Compared with non-depressed subjects, the multivariable odds of cardiac arrest
were increased both among the less severely depressed (OR 1.30, 95% CI 1.04–1.63) and
among those with more severe depression (OR 1.77, 95% CI 1.28–2.45). The association
between depression and cardiac arrest remained even after exclusion of patients who were
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taking antidepressant medications, indicating that depression itself was specifically related
to cardiac arrest risk. In a population-based cohort analysis, Luukinen et al.21 studied 915
individuals aged 70 years or older in a defined area of northern Finland. In multivariable
analyses that included hypertension, diabetes, and congestive heart failure, during 8 year
follow-up, depressive symptoms according to a baseline questionnaire were associated with
increased risk of SCD (HR 2.74, 95% CI 1.37–5.50), whereas the risk of non-sudden death
was not significantly increased. Exclusion of antidepressant users did not change the main
results. In an analysis from the Nurses’ Health Study, among 63,000 females without known
cardiovascular disease, a proxy variable for clinical depression that consisted of Mental
Health Inventory-5 score<53 or antidepressant medication use was associated with SCD in
multivariable models that included hypertension, diabetes, and hypercholesterolemia (HR
2.33, 95% CI 1.47 to 3.70). The relationship of depression to subsequent SCD appeared to
be related to a specific association with antidepressant use, although confounding by
indication could not be ruled out13.
In contrast to the above population-based studies, Irvine et al.22 focused on a high-risk group
of 671 post-myocardial infarction patients with frequent ventricular premature beats by
ambulatory ECG monitoring who were enrolled in the multicenter Canadian Amiodarone
Myocardial Infarction Arrhythmia Trial randomized trial of amiodarone versus placebo. In
analyses that adjusted for prior myocardial infarction and congestive heart failure, Beck
Depression Inventory (BDI) score ≥10 was associated with 2-year SCD (RR 2.45, 95% CI
1.14–5.35) in the placebo group, but not in the amiodarone group. When a measure of
dyspnea and fatigue was added to the model, the relationship between depressive symptoms
and SCD was attenuated by about 30% and was no longer statistically significant (RR 1.73,
95% CI 0.75–3.98), raising the question of whether somatic symptoms may confound the
association between depression and SCD. In another cohort analysis of high-risk patients,
among 645 ICD patients in the Triggers of Ventricular Arrhythmias study, depressive
symptoms assessed by the Center for Epidemiologic Studies-Depression (CES-D) scale
were associated with time to first shock for VT/VF (hazard ratio 3.2, 95% CI 1.1 to 9.9) in
multivariable models that included left ventricular ejection fraction, heart failure class, and
number of prior ICD shocks23. Even in patients who are among the highest risk for
mortality, those with the combination of atrial fibrillation and heart failure, depressive
symptoms predict arrhythmic death, as demonstrated in a substudy of the Atrial Fibrillation-
Congestive Heart Failure (AF-CHF) Trial among 974 patients24.
Anxiety
Although an overall triggering relationship between anxiety and ICD shocks was not seen in
the study by Lampert et al.15, Burg et al.9 found in the same sample that the subgroup of
patients reported anxiety prior to their shock had significantly higher levels of trait anxiety.
In a separate study of 1012 patients with new ICD implant, those in the highest tertile of
anxiety measured by the State-Trait Anxiety Inventory were at increased risk for ventricular
arrhythmias during 1-year follow-up (HR 1.91, 95% CI 1.33–2.75) with adjustment for
variables including coronary artery disease, diabetes, and beta blocker use25. Lampert et
al.26 demonstrated destabilizing effects of mental stress on ventricular arrhythmias using
noninvasive-programmed stimulation to induce ventricular tachycardia with and without
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mental stress in 18 patients with ICDs. Ventricular tachycardia had faster onset and was
more difficult to terminate in patients under mental stress.
Phobic anxiety describes anxiety that is triggered by a specific stimulus and is the largest
category of anxiety disorders affecting between 5%–12% of the population worldwide27.
Kawachi et al.28 used the Crown-Crisp index (CCI) to study the relationship between phobic
anxiety and mortality in the Health Professionals Follow-up Study of 33,999 male health
professionals. During 2 years of follow-up, an elevated CCI score of 3 or more was
associated with elevated risk of cardiac mortality, and this excess risk was due to increased
risk of sudden cardiac death (relative risk 6.08, 95% CI 2.35–15.73) in multivariable
models. In the Nurses’ Health Study, among 72 359 women with no history of
cardiovascular disease, during 12 years of follow-up, women who scored 4 or greater on the
CCI were at higher risk of SCD (HR 1.59, 95% CI 0.97 to 2.60). After adjustment for
possible intermediaries (hypertension, diabetes, and elevated cholesterol), a trend toward
increased risk persisted for SCD (P=0.06)29.
Depression and anxiety often coexist, and the Very Anxious Group Under Scrutiny
(VAGUS) study investigated this issue in 940 patients with history of coronary artery
disease who were undergoing diagnostic cardiac catheterization. This study was unique in
using a ventricular arrhythmia outcome, ascertained from medical records and defined as
ventricular tachycardia (non-sustained and sustained) or ventricular fibrillation. Also, this
study measured both depression according to the BDI and phobic anxiety using the CCI.
During 3 year follow-up, 97 (10.3%) patients had documented ventricular arrhythmia. BDI
score ≥10 was associated with ventricular arrhythmia in multivariable analyses that included
left ventricular ejection fraction and history of arrhythmia (odds ratio 1.4, 95% CI 1.1 to
1.9). With simultaneous inclusion of BDI score and CCI, depressive symptoms (odds ratio
1.3, 95% CI 0.99–1.7) and phobic anxiety (odds ratio 1.3, 95% CI 0.98–1.8) were each
associated with a trend toward increased arrhythmia. A composite index of depression score
and phobic anxiety, however, predicted ventricular arrhythmias with a larger effect size than
either score alone (odds ratio 1.6, 95% CI 1.2–2.1). The VAGUS study suggested that
depression and anxiety may act via common pathways to increase the risk of arrhythmia,
and that arrhythmia may explain the mortality risk associated with these factors in patients
with coronary artery disease30.
Atrial fibrillation
As opposed to ventricular arrhythmia and SCD, there have been fewer studies published
regarding emotional factors and the most common arrhythmia, AF, and the evidence is not
as consistent. In a triggering analysis that used event monitoring and electronic diaries,
Lampert and colleagues observed in 75 patients with paroxysmal or persistent AF that
arrhythmia episodes were more often preceded by negative emotions and less often by
happiness31. In a case-cohort study of a population-based sample from Taiwan consisting of
3888 patients with diagnosis of panic disorder (PD) and 38,880 controls, during follow up as
long as 7 years, crude AF risk was 1.2% in the PD group and 0.9% in the control group.
Multivariable analyses that included age, gender, hypertension, CHF, valvular heart disease,
and chronic obstructive pulmonary disease showed elevated AF risk in PD (HR 1.73, 95%
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CI 1.27–2.37)32. However, in a prospective cohort analysis of 30,746 female health
professionals without known heart disease, global psychological distress according to a 5-
item questionnaire was not associated with AF risk, and neither were specific items
regarding depression and anxiety33. This may be consistent with gender differences in the
association of emotion and AF that has previously been noted in the Framingham Offspring
Study, where baseline levels of tension, anger, and hostility predicted increased 10-year risk
of AF in men, but not in women34,35.
Insights into mechanisms
A frequently postulated mechanism relating the risk of arrhythmia to psychological distress
is cardiac autonomic dysfunction, i.e., sympathetic predominance and parasympathetic
withdrawal. Grippo and colleagues have studied a depressive phenotype in a rat model
through a stress induction, the components of which included exposures such as continuous
overnight illumination, paired housing, and white noise. The rats that were randomly
exposed to the stress induction developed increased heart rate, reduced heart rate variability,
and greater ventricular arrhythmia in response to aconitine infusion36. Carney and
colleagues have demonstrated in the post-MI setting that depressed patients have reduced
heart rate variability, particularly in the very-low-frequency spectrum according to
frequency domain analyses of 24-hour ambulatory electrocardiography (ECG) monitoring37.
An analysis of 311 depressed and 367 non-depressed post-MI patients in the Enhancing
Recovery in Coronary Heart Disease (ENRICHD) clinical trial suggested that reduced heart
rate variability partially mediated the relationship between depression and mortality38.
Emotional factors may also influence arrhythmia risk by affecting the stability of cardiac
repolarization. Experimental anger-recall tasks have evoked T wave alternans in ICD
patients39,40, and furthermore, anger-induced T wave alternans in the laboratory setting
predicted VT/VF episodes in ICD patients41. This work suggests that anger triggers
ventricular arrhythmia in the short term by inducing repolarization instability. Depression
has also been studied for effects on repolarization; Carney et al.42 compared 20 post-
myocardial infarction patients with major depression and 20 post-MI patients without
depression and found that the QT variability index, a marker for ventricular arrhythmia, was
significantly higher in the depressed group. There may be a gender modification with
repolarization abnormalities, as the electrocardiographic QT interval has been observed to
be increased in women, but not in men after acute coronary syndrome43.
Specific regions in the brain may be responsible for mediating the pro-arrhythmic effects of
emotions. Lane and Jennings proposed the “brain-heart laterality hypothesis” suggesting that
lateralization of emotions in the cerebral hemispheres and of autonomic inputs to the
surfaces of the heart contributed to repolarization instability and to SCD44. By
simultaneously measuring brain and heart activity using H2(15)O positron emission
tomography and ECGs during mental and physical stress, Critchley et al.45 demonstrated in
a sample of ten cardiology clinic patients that right lateralized midbrain activity
corresponded to electrocardiographic repolarization abnormalities.
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We can also look to specific cardiac disease processes that involve emotional factors in
order to gain insights of possible mechanisms in the larger population. For instance, in stress
cardiomyopathy, or Takotsubo syndrome, a primary driver is profound catecholamine
surge46,47. Commonalities between the two conditions have prompted speculation that
depression may increase the propensity to develop stress cardiomyopathy48. Depression has
been observed to be relatively common in patients with stress cardiomyopathy48, and
cardiac norepinephrine spillover is elevated in patients with depression and comorbid panic
disorder49,50. In long QT syndrome type 2, caused by a loss of function mutation in the
KCNH2 gene, SCD has been described to occur more frequently in response to sudden
arousal or to emotional stress51. Lane et al.52 observed that among 38 patients with long QT
syndrome, psychological stress was elevated and peak happiness was reduced during the 24
hours prior to cardiac events consisting of syncope, aborted cardiac arrest, or defibrillator
shock.
The relative lack of evidence for an association between negative emotions and AF in long-
term follow-up studies may actually be consistent with the distinct effects of autonomic
stimulation on atrial arrhythmias. As opposed to VT/VF, parasympathetic stimulation may
play an important role in the development of AF53–55, particularly in younger patients56 and
in those with ‘lone’ AF57. Increased heart rate variability, a marker of parasympathetic heart
rate modulation, has been associated with higher risk of recurrent AF after cardioversion58.
Further work is necessary to clarify whether atrial and ventricular arrhythmias have differing
pathophysiologic relationships with emotions.
Potential therapies: the case of depression post-MI
Repeated observational studies continue to validate the relationship between psychological
distress and arrhythmias, particularly VT/VF. In addition, animal models have suggested
that therapies ‘upstream’ from the heart may reduce cardiac risk associated with
psychological distress. In an ischemic pig model, Skinner et al.59 showed that psychological
stress was an important factor in inducing VF, and that behavioral adaptation or
intracerebral beta blocker injection could prevent VF initiation60. Grippo et al.61
demonstrated in a prairie vole model that intravenous oxytocin ameliorated the negative
heart rate and heart rate variability effects, as well as the behavioral responses, to social
isolation.
Most treatment trials involving psychological distress and heart disease have involved
treatment for depression after MI. However, to date there is little or no evidence that treating
depression in such individuals improves cardiovascular outcomes or prevents arrhythmia
events, possibly due to limited power to detect differences in rare endpoints38,62. It may also
be that analogous to the Cardiac Arrhythmia Suppression Trial (CAST) where anti-
arrhythmic therapy resulted in elevated mortality in post-MI patients with frequent
ventricular premature complexes63, treatment of the risk marker (depression) may not target
the relevant mechanism involved in arrhythmia.
Perhaps psychological markers may simply help identify those at increased cardiac risk and
who may benefit from treatment to improve arrhythmia burden. One intriguing study that
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has indicated the importance of psychological factors as a potential risk marker of
arrhythmia treatment is an analysis of the AF-CHF trial. This was a multicenter, randomized
control trial of 1376 patients that compared rhythm control to rate control in patients with
heart failure and atrial fibrillation64. Although there were no differences in cardiovascular
mortality between the two groups in the main trial, a sub-group analysis showed that among
the 233 patients in the highest quartile of anxiety scores, rhythm control improved cardiac
mortality compared with rate control (hazard ratio, 0.54; 95% confidence interval 0.32–0.93;
P=0.022) with a statistically significant treatment interaction (P=0.009)65.
If we consider both the ‘upstream’ and ‘downstream’ therapies that are available for patients
with depression post-MI and that could potentially improve arrhythmia risk, many of them
involve modulation of the autonomic nervous system (Figure 2). Vagus nerve stimulation is
appealing in possibly having simultaneous benefits for both conditions66,67. However, only
one of the therapies, the ICD, has been proven to reduce mortality from arrhythmia in heart
disease patients, albeit with high device costs, with a number needed to treat of
approximately 18 primary prevention devices to save one person’s life, and with continued
unaddressed burden of SCD post-MI68. Dealing with the public health problem of SCD may
require improved identification of individuals who are at high enough risk for ventricular
arrhythmia to benefit from an ICD, and psychological distress is a potential candidate
marker of this risk. For instance, ICD therapy is currently indicated for primary prevention
of SCD in post-MI patients with reduced left ventricular ejection fraction<0.35, especially
with symptomatic heart failure69. Using heart failure symptoms to help identify patients who
would benefit from ICDs involves several parallels with potentially using psychological
states such as depression. For example, the diagnosis of depression is ultimately a clinical
one, and depends to a large extent on subjective assessments taken from the perspective of
the patient. In a similar fashion, assigning heart failure functional class can depend on
relatively subjective assessments that nonetheless carry prognostic importance. Also, heart
failure symptoms and depressive symptoms can wax and wane over time, especially with
treatment, yet patients are often characterized within a certain bandwith of clinical status.
Ultimately, heart failure is a modifier condition that helps identify patients who would
derive mortality benefit from ICD therapy, and is not a critical participant in arrhythmia per
se. So too, conditions such as depression may help identify more individuals who have the
potential to benefit from ICD therapy, beyond current indications.
Future directions and conclusions
It is apparent that psychological distress and negative emotions are important factors in the
development of arrhythmia, yet many questions remain. It is not clear which matters more in
the development of arrhythmia, a person’s psychological substrate or the time-limited (and
more modifiable) emotional states through which he or she passes. This has important
implications for the possibility of improving arrhythmia burden through therapies aimed at
the emotional condition of patients. Also, other than T wave alternans in the case of anger-
induced arrhythmia, there are still relatively few physiologic indicators that might help
identify those patients at greatest risk for arrhythmia due to psychological distress. Ideally,
relatively simple clinical tests, such as the 12-lead ECG or Holter monitor, could provide
some insight when combined with comprehensive assessments of exposure to emotional
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stressors, but this remains to be clarified. The reasons for observed gender differences in the
relationship between arrhythmia and psychological distress, such as in stress
cardiomyopathy, are also not resolved. Perhaps the identification of mechanisms for these
differences might help the development of therapies.
It is an exciting time in the field of behavioral cardiology, as research that integrates the
brain and the heart has opened new lines of investigation. In addition to the proposed
mechanisms mentioned here, medication adherence and lifestyle modification are also under
more rigorous scrutiny as possible mediators of the cardiac risk of psychological distress70.
As cardiologists have learned from prior experience (CAST), reducing the burden of disease
from cardiac arrhythmia requires a comprehensive approach that involves the patient, not
just the ECG. In a similar fashion, the recognition is spreading that reduction of arrhythmia
risk in patients with psychological distress needs to incorporate the heart as well as the
mind.
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CES-D Center for Epidemiologic Studies-Depression
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PD panic disorder
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Schematic representation of the proposed relationship between psychological distress and
cardiac arrhythmias. Emotions can predict cardiovascular substrate at risk for arrhythmias
and can trigger arrhythmias. Arrhythmias and high-risk heart conditions can precipitate
psychological distress.
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Schematic representation of potential therapies for sudden cardiac death in high-risk post-MI
patients suffering from depression.
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